Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$8.46 0.03 (0.36%)
2/9/2010 4:00 PM

Albany Molecular Research, Inc. (AMRI)

CAPS Rating:
***

The Company is a global chemistry-based drug discovery and development company focused on identifying and developing novel biologically active small molecules with applications in the drug market.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating AMRI

Add Stock to Watchlist

What the Community Thinks

Total Members

86 Outperforms
11 Underperforms
 

All-Stars

34 Outperforms
5 Underperforms
 

Wall Street

1 Outperforms
1 Underperforms
 

Members bullish on AMRI are also bullish on:

Members bearish on AMRI are also bearish on:

Ticker Tags

Life Sciences Tools and Services (53), Value (1901), Defensive (1457), Micro Cap (4701), Healthcare (711)
Suggest a tag

Albany Molecular Research, Inc. At A Glance

Current Price: $8.46
Last Trade Time: 2/9/2010 4:00 PM
Open: $0.00
Previous Close: $8.43
Daily Range: $8.43 - $9.42
52-Week Range: $7.31 - $12.56
Volume: 209,508
Market Cap: $267.71M
P/E Ratio: 46.37
Compare Our Special Broker Offers!

Stock Trends

AMRI VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

0

Albany Molecular Research, Inc. (AMRI)

Avatar NeroSagetrade (90.44) Submitted: 10/09/07 11:05 PM

Albany Molecular Research is another case of the slow and steady turtle executing with a solid management team to deliver results. The past four quarters have shown rather large earnings beats and at 31 times earnings and with $3.14 per share in cash I think they can solidly deliver 15% stock price ...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 13 :   1 2 3 Next »

Recs

0

 (AMRI)

Avatar Investin1 (49.03) Submitted: 12/29/09 4:17 AM : Underperform Start Price: $9.43 AMRI Score: 5.16

Negative EPS growth, and negative revenue. Prospective gains looks slim as company's FCF is too small relative to R&D. Limited niche for company as larger pharma companies reduce costs by integrating drug development within.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AMRI)

Avatar brianpivar (92.49) Submitted: 11/04/09 8:15 PM : Underperform Start Price: $8.16 AMRI Score: -2.20

EPS 08: .62 p/e 13.1
EPS 09: .05 p/e 162.8
EPS 10: .13 p/e 62.62

Fundamentally speaking, this is a sell

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AMRI)

Avatar dusand (97.61) Submitted: 9/18/09 10:25 AM : Outperform Start Price: $8.29 AMRI Score: 1.99

Profitable pharmacy research and development company with good valuation ratios and low debt. Also, I feel the chart has already reached the bottom.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AMRI)

Avatar NWTOGME (< 20) Submitted: 10/04/08 3:19 PM : Outperform Start Price: $14.21 AMRI Score: -43.13

L/R D/E ratio's look good.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AMRI)

Avatar equalfuture (< 20) Submitted: 4/10/08 4:52 AM : Outperform Start Price: $11.74 AMRI Score: -10.07

BUYING AT 5 PER SHARE, stock is valued in my fair value estimates at 5.40 a share i expect movement at this price in late summer.





good company worth 5 or more a share.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 13 :   1 2 3 Next »

Wall Street

Results 1 - 2 of 2  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackJimCramer < 20 01/24/08 Underperform 3W $13.21-35.96%-17.22%+18.73
TrackSoros 82.58 09/30/07 Outperform NS $15.10-43.97%-26.38%-17.60 Toggle the visibility of 60-Second Pitch and replies

Results 1 - 2 of 2  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD03 187ms